Nuevas Terapias en Salud Mental

  • Cognición en esquizofrenia
  • Rehabilitación cognitiva en esquizofrenia
  • Ejercicio físico intensivo en esquizofrenia
  • Ejercicio físico intensivo en depresión
  • Ensayos clínicos fase II y III para esquizofrenia, trastorno depresivo mayor y trastorno bipolar
  • Farmacontaminación
  • Farmacovigilancia
  • Uso racional del medicamento
  • Neuromodulación

EDUARDO JOSÉ ELIZAGÁRATE ZABALA

Jefe de Servicio de Psiquiatría

PEDRO MANUEL SÁNCHEZ GÓMEZ

Red de Salud Mental Araba

ISABEL ALONSO DURANA

Red de Salud Mental Araba

MARÍA OLÁRIZU OLALDE ORTIZ

Red de Salud Mental Araba

PAOLA CARRERA ABAD

Red de Salud Mental Araba

UNAX LERTXUNDI ETXEBARRIA

Red de Salud Mental Araba

NAGORE IRIARTE YOLLER

Red de Salud Mental Araba

ALEJANDRO BALLESTROS PRADOS

Red de Salud Mental Araba

FÉLIX INCHAUSTI GÓMEZ

Red de Salud Mental Araba

As We Were and as We Should Be, Combined Exercise Training in Adults with Schizophrenia: CORTEX-SP Study Part I.
Tous-Espelosin, M, de Azua, SR, Iriarte-Yoller, N, Sanchez, PM, Elizagarate, E, Maldonado-Martin, S.

MEDICINE & SCIENCE IN SPORTS & EXERCISE, 56, 73-81. 2024
Medication impact on oral health in schizophrenia.
Urien, Leire, Jauregizar, Nerea, Lertxundi, Unax, Fernandez, Unai, Morera-Herreras, Teresa.

MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 29, 51-57. 2024
Perfluorohexyloctane: Do we really need a PFAS for the treatment of Dry Eye Disease?.
Garcia-Blasco, Camino, Domingo-Echaburu, Saioa, Orive, Gorka, Lertxundi, Unax.

SCIENCE OF THE TOTAL ENVIRONMENT, 901, . 2023
Investigating the relationship between negative symptoms and metacognitive functioning in psychosis: An individual participant data meta-analysis.
McGuire, N., Gumley, A., Hasson-Ohayon, I., Allan, S., Aunjitsakul, W., Aydin, O., Bo, S., Bonfils, K.A., Bröcker, A.-L., de Jong, S., Dimaggio, G., Inchausti, F., Jansen, J.E., Lecomte, T., Luther, L., MacBeth, A., Montag, C., Pedersen, M.B., Pijnenborg, G.H.M., Popolo, R., Schwannauer, M., Trauelsen, A.-M., van Donkersgoed, R., Wu, W., Wang, K., Lysaker, P.H., McLeod, H..

PSYCHOLOGY AND PSYCHOTHERAPY-THEORY RESEARCH AND PRACTICE, 96, 918-933. 2023
Moderators of functional improvement after integrative cognitive remediation in schizophrenia: Toward a personalized treatment approach.
Sampedro, A., Peña, J., Sánchez, P., Ibarretxe-Bilbao, N., Iriarte-Yoller, N., Pavón, C., Ojeda, N..

PSYCHIATRY RESEARCH, 329, . 2023
Occurrence and ecological risk assessment of organic UV filters in coastal waters of the Iberian Peninsula.
Mozas-Blanco, S., Rodríguez-Gil, J.L., Kalman, J., Quintana, G., Díaz-Cruz, M.S., Rico, A., López-Heras, I., Martínez-Morcillo, S., Motas, M., Lertxundi, U., Orive, G., Santos, O., Valcárcel, Y..

MARINE POLLUTION BULLETIN, 196, . 2023
Method Based on Ultrafiltration to Obtain a Plasma Rich in Platelet and Plasma Growth Factors.
Mercader Ruiz, J., Beitia, M., Delgado, D., Sánchez, P., Guadilla, J., Pérez de Arrilucea, C., Benito-Lopez, F., Basabe-Desmonts, L., Sánchez, M..

Journal Of Clinical Medicine, 12, . 2023
New Formulation of Platelet-Rich Plasma Enriched in Platelet and Extraplatelet Biomolecules Using Hydrogels.
Mercader Ruiz, J., Beitia, M., Delgado, D., Sánchez, P., Arnaiz, M.J., López de Dicastillo, L., Benito-Lopez, F., Basabe-Desmonts, L., Sánchez, M..

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24, . 2023
Extrapyramidal adverse events and anticholinergics use after the long-term treatment of patients with schizophrenia with the new long-acting antipsychotic Risperidone ISM®: results from matching-adjusted indirect comparisons versus once-monthly formulations of Paliperidone palmitate and Aripiprazole monohydrate in 52-week studies.
Sánchez, P., Álamo, C., Almendros, M., Schlueter, M., Tasoulas, A., Martínez, J..

ANNALS OF GENERAL PSYCHIATRY, 22, . 2023
Correlation between SARS-CoV-2 RNA concentration in wastewater and COVID-19 cases in community: A systematic review and meta-analysis.
Li, X., Zhang, S., Sherchan, S., Orive, G., Lertxundi, U., Haramoto, E., Honda, R., Kumar, M., Arora, S., Kitajima, M., Jiang, G..

JOURNAL OF HAZARDOUS MATERIALS, 441, . 2023
Safe levels of pharmaceuticals in groundwater.
Egana, Iker, Domingo-Echaburu, Saioa, Orive, Gorka, Lertxundi, Unax.

SCIENCE OF THE TOTAL ENVIRONMENT, 886, . 2023
'It Helped Me to Disconnect My Mind from the Problems': The Subjective Experiences of People with Schizophrenia Taking Part in a Concurrent Exercise Program..
Tous-Espelosin M, Crone D, Ruiz de Azua S, Iriarte-Yoller N, Sampedro A, Maldonado-Martín S.

ISSUES IN MENTAL HEALTH NURSING, 44, 717-725. 2023
Pharmaceuticals in hospital wastewaters: an analysis of the UBA's pharmaceutical database.
Alzola-Andres, Maitane, Domingo-Echaburu, Saioa, Segura, Yolanda, Valcarcel, Yolanda, Orive, Gorka, Lertxundi, Unax.

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 30, 99345-99361. 2023
Patient's preferences and shared decision-making: Considering environmental aspects in head lice treatment.
Garcia-Blasco, Camino, Domingo-Echaburu, Saioa, Orive, Gorka, Lertxundi, Unax.

Sustainable Chemistry and Pharmacy, 33, . 2023
Psychopathological networks in psychosis: Changes over time and clinical relevance. A long-term cohort study of first-episode psychosis.
Gil-Berrozpe, GJ, Peralta, V, Sánchez-Torres, AM, Moreno-Izco, L, de Jalón, EG, Peralta, D, Janda, L, Cuesta, MJ, BALLESTEROS, A..

SCHIZOPHRENIA RESEARCH, 252, 23-32. 2023
Is the Environmental Risk of Metformin Underestimated?.
Lertxundi, Unax, Domingo-Echaburu, Saioa, Barros, Susana, Santos, Miguel Machado, Neuparth, Teresa, Quintana, Jose Benito, Rodil, Rosario, Montes, Rosa, Orive, Gorka.

Environmental science & technology, 57, 8463-8466. 2023
Analyzing structural and functional brain changes related to an integrative cognitive remediation program for schizophrenia: A randomized controlled trial..
Sampedro, Agurne, Ibarretxe-Bilbao, Naroa, Pena, Javier, Cabrera-Zubizarreta, Alberto, Sanchez, Pedro, Gomez-Gastiasoro, Ainara, Iriarte-Yoller, Nagore, Pavon, Cristobal, Tous-Espelosin, Mikel, Ojeda, Natalia.

SCHIZOPHRENIA RESEARCH, 255, 82-92. 2023
Analysis of heat stroke and heat exhaustion cases in EudraVigilance pharmacovigilance database.
Gamboa, L, Lafuente, AS, Morera-Herreras, T, Garcia, M, Aguirre, C, Lertxundi, U.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 79, 679-685. 2023
Analyzing the potential environmental impact of NIOSH list of hazardous drugs (group 2).
Abajo, Z., Jimenez, A., Domingo-Echaburu, S., Valcárcel, Y., Segura, Y., Orive, G., Lertxundi, U..

SCIENCE OF THE TOTAL ENVIRONMENT, 873, . 2023
Comprehensive micropollutant characterization of wastewater during Covid-19 crisis in 2020: Suspect screening and environmental risk prioritization strategy.
Lopez-Herguedas, N., Irazola, M., Alvarez-Mora, I., Orive, G., Lertxundi, U., Olivares, M., Zuloaga, O., Prieto, A..

SCIENCE OF THE TOTAL ENVIRONMENT, 873, . 2023
Por una farmacia más sostenible.
Lertxundi, U., Orive, G..

Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria, 47, 53-54. 2023
El protocolo del Proyecto PSICE: evaluación del protocolo unificado transdiagnóstico para adolescentes con síntomas emocionales en contextos educativos.
Eduardo Fonseca Pedrero, Alicia Pérez de Albéniz Iturriaga, Susana Al-Halabi Díaz, Beatriz Lucas Molina, Javier Ortuño Sierra, Adriana Díez Gómez del Casal, Julia Pérez Sáenz, Félix Inchausti, Ana Vanesa Valero García, Andrea Gutiérrez García, Rebeca Aritio Solana, Gabriel Ródenas Perea, María Paloma de Vicente Clemente, Ana Ciarreta López, Martin Debbané.

CLINICA Y SALUD, 34, 15-22. 2023
Recovery-Focused Metacognitive Interpersonal Therapy (MIT) for Adolescents with First-Episode Psychosis.
Inchausti, F, García-Mieres, H, Garcia-Poveda, NV, Fonseca-Pedrero, E, MacBeth, A, Popolo, R, Dimaggio, G.

Journal of Contemporary Psychotherapy, 53, 9-17. 2023
A clinical staging model of psychotic disorders based on a long-term follow-up of first-admission psychosis: A validation study.
Peralta, V., de Jalón, E.G., Moreno-Izco, L., Peralta, D., Janda, L., Sánchez-Torres, A.M., Cuesta, M.J., Ballesteros, A., Fañanás, L., Gil-Berrozpe, G., Hernández, R., Lorente, R., Papiol, S., Ribeiro, M., Rosero, A., Zandio, M..

PSYCHIATRY RESEARCH, 322, 115109-115109. 2023
Autocuidado del terapeuta.
Alberto Gimeno Peón, Javier Prado Abril, Joaquín Pastor Morales, Félix Inchausti.

Manual De Psicología De La Conducta Suicida, , 645-667. 2023
DOI:
Los efectos y posibles consecuencias de la contaminación por fármacos son mayores de lo que podríamos imaginar..
Gorka Orive Arroyo (entrevistado), Unax Lertxundi Etxebarria (entrevistado).

Acofar: Revista De La Distribución Farmacéutica Cooperativista, 578, 10-13. 2023
DOI:
Empirical validity of Leonhard's psychoses: A long-term follow-up study of first-episode psychosis patients..
Cuesta MJ, Sánchez-Torres AM, García de Jalón E, Moreno-Izco L, Gil-Berrozpe GJ, Zarzuela A, Papiol S, Fañanás L, Peralta V, SEGPEPs Group.

SCHIZOPHRENIA RESEARCH, 263, 237-245. 2023
Detección de psicofármacos y drogas de abuso en diferentes matrices ambientales en España..
LERTXUNDI ETXEBARRIA, UNAX.

Congreso Nacional Sociedad Española de Farmacia Hospitalaria, , 440. 2023
DOI:
Contaminación ambiental por macrólidos en España..
LERTXUNDI ETXEBARRIA, UNAX.

Congreso Nacional Sociedad Española de Farmacia Hospitalaria, , 360. 2023
DOI:
Análisis de aguas residuales con fines epidemiológicos en un centro penitenciario..
LERTXUNDI ETXEBARRIA, UNAX, ORIVE ARROYO, GORKA.

Congreso Nacional Sociedad Española de Farmacia Hospitalaria, , . 2023
DOI:
Evaluacion del riesgo ambiental de macrolidos en aguas superficiales..
LERTXUNDI ETXEBARRIA, UNAX.

Congreso Nacional Sociedad Española de Farmacia Hospitalaria, , . 2023
DOI:
Hazardous drugs (NIOSH's list-group 1) in healthcare settings: Also a hazard for the environment? (vol 817, 152954, 2022).
Domingo-Echaburu, S., Lopez de Torre-Querejazu, A., Valcarcel, Y., Orive, G., Lertxundi, U..

SCIENCE OF THE TOTAL ENVIRONMENT, 836, . 2022
Environmental risk of pharmaceuticals: Let us look at the whole package.
Lertxundi U, Domingo-Echaburu S, Orive G.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 88, 3918-3919. 2022
Use of illicit drugs, alcohol and tobacco in Spain and Portugal during the COVID-19 crisis in 2020 as measured by wastewater-based epidemiology.
Estévez-Danta, A., Bijlsma, L., Capela, R., Cela, R., Celma, A., Hernández, F., Lertxundi, U., Matias, J., Montes, R., Orive, G., Prieto, A., Santos, M.M., Rodil, R., Quintana, J.B..

SCIENCE OF THE TOTAL ENVIRONMENT, 836, . 2022
Greening the pharmacy.
Orive, G., Lertxundi, U., Brodin, T., Manning, P..

SCIENCE, 377, 259-260. 2022
Artificial neural network-based estimation of COVID-19 case numbers and effective reproduction rate using wastewater-based epidemiology..
Jiang G, Wu J, Weidhaas J, Li X, Chen Y, Mueller J, Li J, Kumar M, Zhou X, Arora S, Haramoto E, Sherchan S, Orive G, Lertxundi U, Honda R, Kitajima M, Jackson G.

WATER RESEARCH, 218, 118451-118451. 2022
Subacute thyroiditis and COVID-19 vaccines: a case/non-case study..
Garcia, Montserrat, Albizua-Madariaga, Itziar, Lertxundi, Unax, Aguirre, Carmelo.

Endocrine, 77, 480-485. 2022
Pharmaceutical Simplification: Killing Two Birds with One Stone..
Lertxundi U, Domingo-Echaburu S, Orive G.

Environmental science & technology, 56, 3-3. 2022
Drugs used during the COVID-19 first wave in Vitoria-Gasteiz (Spain) and their presence in the environment.
Domingo-Echaburu, S, Irazola, M, Prieto, A, Rocano, B, De Torre-Querejazu, AL, Quintana, A, Orive, G, Lertxundi, U.

SCIENCE OF THE TOTAL ENVIRONMENT, 820, 153122-153122. 2022
Hazardous drugs (NIOSH's list-group 1) in healthcare settings: Also a hazard for the environment?.
Domingo-Echaburu S, Lopez de Torre-Querejazu A, Valcárcel Y, Orive G, Lertxundi U.

SCIENCE OF THE TOTAL ENVIRONMENT, 817, 152954-152954. 2022
El caso de los buitres y el diclofenaco es, sin duda, el más conocido y el más dramático.
Gorka Orive Arroyo, Unax Lertxundi Etxebarría.

Farmacéuticos: Revista Del Consejo General De Colegios Oficiales De Farmacéuticos, 475, 40-42. 2022
DOI:
Metacognitive interpersonal group therapy for adolescents with avoidant personality disorder: The case of Sofia.
Inchausti, F., Velázquez-Basterra, G., Fonseca-Pedrero, E., MacBeth, A., Popolo, R., Dimaggio, G..

JOURNAL OF CLINICAL PSYCHOLOGY, 78, 1579-1589. 2022
Drug pollution & Sustainable Development Goals..
Domingo-Echaburu S, Dávalos LM, Orive G, Lertxundi U.

SCIENCE OF THE TOTAL ENVIRONMENT, 800, 149412-149412. 2021
Knowledge and Attitude About Ecopharmacovigilance Among Pharmacy Students in the University of the Basque Country (Spain). A Pilot Study.
Domingo-Echaburu, S, Lertxundi, U, Orive, G, Alzola-Elizondo, U, Sanchez-Perez, A.

Drug Safety, 44, 1426-1426. 2021
DOI:
Venlafaxine and desvenlafaxine to be included in the surface water Watch List..
Lertxundi, Unax, Domingo-Echaburu, Saioa, Hernandez, Rafael, Medrano, Juan, Orive, Gorka.

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 55, 1112-1112. 2021
Cross-Validation of Predictive Equation for Cardiorespiratory Fitness by Modified Shuttle Walk Test in Adults with Schizophrenia: A Secondary Analysis of the CORTEX-SP Study..
Tous-Espelosin M, Ruiz de Azua S, Iriarte-Yoller N, Sanchez PM, Elizagarate E, Sampedro A, Maldonado-Martín S.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 18, . 2021
Cognitive, creative, functional, and clinical symptom improvements in schizophrenia after an integrative cognitive remediation program: a randomized controlled trial.
Sampedro, A, Pena, J, Sanchez, P, Ibarretxe-Bilbao, N, Gomez-Gastiasoro, A, Iriarte-Yoller, N, Pavon, C, Tous-Espelosin, M, Ojeda, N.

Npj Schizophrenia, 7, 52-52. 2021
Environmental pollution with psychiatric drugs.
Argaluza, J, Domingo-Echaburu, S, Orive, G, Medrano, J, Hernandez, R, Lertxundi, U.

World Journal of Psychiatry, 11, 791-804. 2021
Environmental contamination by pet pharmaceuticals: A hidden problem..
Domingo-Echaburu S, Lertxundi U, Boxall ABA, Orive G.

SCIENCE OF THE TOTAL ENVIRONMENT, 788, 147827-147827. 2021
Do cariprazine and brexpiprazole cause impulse control symptoms? A case/non-case study..
Zazu, Leire, Morera-Herreras, Teresa, Garcia, Montserrat, Aguirre, Carmelo, Lertxundi, Unax.

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 50, 107-111. 2021
Estimation of illicit amphetamine consumption using wastewater based epidemiology: A tiny contribution..
Lertxundi U, Domingo-Echaburu S, Orive G.

SCIENCE OF THE TOTAL ENVIRONMENT, 779, 146349-146349. 2021
Ivermectin & COVID-19: Let's keep a One Health perspective..
Domingo-Echaburu S, Orive G, Lertxundi U.

Sustainable Chemistry and Pharmacy, 21, 100438-100438. 2021
Tramadol-induced hiccups: a case-noncase study in the European pharmacovigilance database..
Garcia, Montserrat, Lertxundi, Unax, Aguirre, Carmelo.

Therapeutic Advances in Drug Safety, 12, . 2021
Rational use of drugs as a source control measure to fight drug pollution..
Lertxundi U, Domingo-Echaburu S, Orive G.

JOURNAL OF HAZARDOUS MATERIALS, 410, 124664-124664. 2021
Redefining the "rational use of medicines".
Orive, G, Domingo-Echaburu, S, Lertxundi, U.

Sustainable Chemistry and Pharmacy, 20, . 2021
The impact of creativity on functional outcome in schizophrenia: a mediational model.
Sampedro, A, Pena, J, Sanchez, P, Ibarretxe-Bilbao, N, Iriarte-Yoller, N, Pavon, C, Hervella, I, Tous-Espelosin, M, Ojeda, N.

Npj Schizophrenia, 7, 14-14. 2021
SGLT2 Inhibitors and Bladder Cancer: Analysis of Cases Reported in the European Pharmacovigilance Database.
Garcia, M, Arteche-Martinez, U, Lertxundi, U, Aguirre, C.

JOURNAL OF CLINICAL PHARMACOLOGY, 61, 187-192. 2021
Antipsychotics as environmental pollutants: An underrated threat?.
Escudero, J, Munoz, J L, Morera-Herreras, T, Hernandez, R, Medrano, J, Domingo-Echaburu, S, Barcelo, D, Orive, G, Lertxundi, U.

SCIENCE OF THE TOTAL ENVIRONMENT, 769, 144634-144634. 2021
Clinical, physical, physiological, and cardiovascular risk patterns of adults with schizophrenia: CORTEX-SP study: Characterization of adults with schizophrenia..
Tous-Espelosin M, de Azua SR, Iriarte-Yoller N, MartínezAguirre-Betolaza A, Sanchez PM, Corres P, Arratibel-Imaz I, Sampedro A, Peña J, Maldonado-Martín S.

PSYCHIATRY RESEARCH, 295, 113580-113580. 2021
Pharmacotherapeutic management of Parkinson's disease inpatients: how about asking hospital pharmacists?.
Lertxundi Etxebarria, Unax, Palacios-Zabalza, Itziar, Ibarrondo, Itziar, Domingo-Echaburu, Saioa, Hernandez, Rafael, Isla, Arantxa, Solinis, Marian.

EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 28, 140-145. 2020
Virus, bats and drugs.
Orive, G, Lertxundi, U.

Reviews on Environmental Health, 35, 301-302. 2020
Early SARS-CoV-2 outbreak detection by sewage -based epidemiology.
Orive, G, Lertxundi U, Barcelo D.

SCIENCE OF THE TOTAL ENVIRONMENT, 732, 139298-139298. 2020
Do we really need to invoke heroic measures for early SARS-CoV-2 outbreak detection?.
Orive, G, Lertxundi, U, Barcelo, D.

EUROPEAN JOURNAL OF EPIDEMIOLOGY, 35, 613-614. 2020
It's about time healthcare professionals and academics start thinking about drug pollution.
Lertxundi, U, Domingo-Echaburu, S, Orive, G.

Sustainable Chemistry and Pharmacy, 16, . 2020
Mass drug administration: time to consider drug pollution?.
Orive, G, Lertxundi, U.

LANCET, 395, 1112-1113. 2020
Drug pollution and pharmacotherapy in psychiatry: A "platypus" in the room..
Lertxundi U, Hernández R, Medrano J, Orive G.

EUROPEAN PSYCHIATRY, 63, . 2020
Effect of psychiatric symptoms and quality of life on cognitive performance in HCV patients..
García-Guerrero MA, Sánchez Gómez P, Peña Lasa J, Portu Zapirain J, Elizagárate Zabala E, Gorria Bernal V, Ojeda Del Pozo N.

REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 13, 22-30. 2020
Investigating the relationship between specific negative symptoms and metacognitive functioning in psychosis: A systematic review.
McGuire, N., Gumley, A., Hasson-Ohayon, I., Allan, S., Aunjitsakul, W., Aydin, O., Bo, S., Bonfils, K.A., Bröcker, A.-L., de Jong, S., Dimaggio, G., Inchausti, F., Jansen, J.E., Lecomte, T., Luther, L., MacBeth, A., Montag, C., Pedersen, M.B., Pijnenborg, G.H.M., Popolo, R., Schwannauer, M., Trauelsen, A.-M., van Donkersgoed, R., Wu, W., Wang, K., Lysaker, P.H., McLeod, H..

PSYCHOLOGY AND PSYCHOTHERAPY-THEORY RESEARCH AND PRACTICE, , .